ALFA Finder
13:37 IST
BSE
Board Meeting Date
Lasa Supergenerics Board Meeting Date
Lasa Supergenerics scheduled its Board meeting for 14 Nov 2026 to approve Q1 and H1 FY27 results. No financial figures or decisions are disclosed yet.
Lasa Supergenerics Ltd
- Share price
- ₹4.22
- Market cap
- ₹21.14 Cr
- Revenue (annual)
- ₹25.14 Cr
- Net profit (annual)
- ₹-34.09 Cr
- P/E (TTM)
- -1.3×Sector 43.8×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
17:05 IST
BSE
Other Announcement
Lasa Supergenerics Other Announcement
Lasa Supergenerics Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure is a routine regulatory requirement.
17:01 IST
BSE
Annual General Meeting
Lasa Supergenerics Annual General Meeting
Lasa Supergenerics Limited held its 11th Annual General Meeting on September 30, 2026. Seven business items, including appointment of a director and borrowing powers, were discussed.
16:33 IST
BSE
Annual Report
Lasa Supergenerics Annual Report
Lasa Supergenerics Ltd has submitted its 11th Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 30, 2026.